Dose-response and Therapeutic Time-window of Compound 21: a Randomized Preclinical Trial in Rat Model of Thromboembolic Stroke

被引:0
|
作者
Ishrat, Tauheed
Fouda, Abdelrahman Y.
Pillai, Bindu
Eldahshan, Wael
Ahmed, Heba
Waller, Jennifer L.
Ergul, Adviye
Fagan, Susan C.
机构
[1] Univ Georgia, Augusta, GA USA
[2] Georgia Regents Univ, Augusta, GA USA
关键词
Compound C21; angiotensin type II receptor agonist; embolic middle cerebral artery occlusion; functional outcome; ischemic stroke; Stroke recovery; Angiotensin II; Neuroprotection; Infarct size;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
WP113
引用
收藏
页数:3
相关论文
共 34 条
  • [31] Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke
    Zhang, L
    Zhang, ZG
    Zhang, RL
    Morris, D
    Lu, M
    Coller, BS
    Chopp, M
    CIRCULATION, 2003, 107 (22) : 2837 - 2843
  • [32] Prospective, randomized, blinded, and placebo-controlled study of Cerebrolysin dose-response effects on long-term functional outcomes in a rat model of mild traumatic brain injury
    Zhang, Yanlu
    Chopp, Michael
    Zhang, Zheng Gang
    Zhang, Yi
    Zhang, Li
    Lu, Mei
    Zhang, Talan
    Winter, Stefan
    Brandstaetter, Hemma
    Mahmood, Asim
    Xiong, Ye
    JOURNAL OF NEUROSURGERY, 2018, 129 (05) : 1295 - 1304
  • [33] Dose-response and time course of specific IgE and IgG after single and repeated topical skin exposure to dry trimellitic anhydride powder in a Brown Norway rat model
    Zhang, XD
    Murray, DK
    Lewis, DM
    Siegel, PD
    ALLERGY, 2002, 57 (07) : 620 - 626